Vesta
Approach
Company
Careers
News & Resources
Login
Contact
FEATURED
Artificial Intelligence Biomarkers Predict Poor Efficacy of Bacillus Calmette-Guérin Rechallenge in Previously Bacillus Calmette-Guérin–Treated Nonmuscle-Invasive Bladder Cancer
July 1, 2025
News & Resources
Latest News
Artificial Intelligence Biomarkers Predict Poor Efficacy of Bacillus Calmette-Guérin Rechallenge in Previously Bacillus Calmette-Guérin–Treated Nonmuscle-Invasive Bladder Cancer
Journal of Urology
July 2025
Artificial Intelligence Biomarkers Predict Poor Efficacy of Bacillus Calmette-Guérin Rechallenge in Previously Bacillus Calmette-Guérin–Treated Nonmuscle-Invasive Bladder Cancer
Journal of Urology
July 2025
Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
Businesswire
June 2025
Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
Businesswire
June 2025
Computational Histology Artificial Intelligence Enhances Risk Stratification of High-grade Ta Non–muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current EAU and AUA Stratification Schemes
European Urology
June 2025
Computational Histology Artificial Intelligence Enhances Risk Stratification of High-grade Ta Non–muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current EAU and AUA Stratification Schemes
European Urology
June 2025